Trial · NCT06644690
Creative Dance-Supported CO-OP Approach in Older Adults With Mild Cognitive Impairment
NCT06644690, Not applicable, Completed, Çankırı Karatekin University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Creative Dance-Supported CO-OP Approach in Older Adults With Mild Cognitive Impairment. Trials, record NCT06644690. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06644690
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Creative Dance-Supported CO-OP Approach in Older Adults With Mild Cognitive Impairment
- NCT number
- NCT06644690
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 26 participants, actual
- Lead sponsor
- Çankırı Karatekin University
- Conditions
- Mild Cognitive Impairment (MCI)
- Interventions
- CO-OP with Creative Dance, CO-OP Only
- First posted
- 2024-10-16
- Last updated
- 2025-12-19
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in Executive Function as Measured by the Trail Making Test Part B | Baseline, immediately after the 8-week intervention, and at 3 and 6 months post-intervention | The primary outcome is the change in executive function, assessed using the Trail Making Test Part B, from baseline to the end of the 8-week intervention. The test evaluates the participant's ability to switch between tasks, a key component of executive function. Improvements in test scores indicate enhanced cognitive flexibility and task-switching abilities. This outcome is critical for evaluating the impact of the CO-OP approach (with or without creative dance) on executive function in participants with mild cognitive impairment. If you have additional primary measures, they can be included, but typically this would be the focus. |
| Secondary | Change in Attention as Measured by the Stroop Test | Baseline, immediately after the 8-week intervention, and at 3 and 6 months post-intervention | This secondary outcome evaluates changes in attention and cognitive control, assessed using the Stroop Test. The test measures participants' ability to inhibit cognitive interference and focus on relevant stimuli. Improvement in scores from baseline to post-intervention and follow-up points will indicate enhanced attention and cognitive control |
| Secondary | Change in Memory Performance as Measured by the Rey-Osterrieth Complex Figure Test | Baseline, immediately after the 8-week intervention, and at 3 and 6 months post-intervention | This secondary outcome assesses changes in visual memory and organizational skills, using the Rey-Osterrieth Complex Figure Test. Participants' ability to recall and reproduce complex figures will be measured at baseline, post-intervention, and during follow-up assessments at 3 and 6 months. Improvements in scores will indicate enhanced memory function. |
| Secondary | Change in Dual-Task Performance as Measured by Walking While Performing a Cognitive Task" | Baseline, immediately after the 8-week intervention, and at 3 and 6 months post-intervention | This secondary outcome evaluates the participants' ability to perform a motor task (walking) while simultaneously engaging in a cognitive task (such as recalling numbers or words). The assessment will measure the impact of the intervention on dual-task performance, with data collected at baseline, post-intervention, and at 3 and 6 months follow-up. Improvement in dual-task performance will indicate better cognitive-motor integration and executive function. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers22
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests4
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Task Switching Test | Primary outcome | ConductCognition |
| Trail Making Test B | Primary outcome | ConductCognition |
| Complex Figure Copy and Recall | Secondary outcome | ConductCognition |
| Stroop Color-Word Test | Secondary outcome | ConductCognition |
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06644690
GET https://conductscience.org/api/trials/v1/NCT06644690/papers?page=2